Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Hemoglobin
    June 2024
  1. CHIGUER A, Lyahyai J, El Kadiri Y, Cherkaoui Jaouad I, et al
    Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia.
    Hemoglobin. 2024 Jun 4:1-4. doi: 10.1080/03630269.2024.2360456.
    >> Share

    May 2024
  2. RAO E, Patel D, Saxena N, Saha KB, et al
    Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint.
    Hemoglobin. 2024;48:212-213.
    >> Share

  3. ASRI AS, Samsuddin MH, Jalil N, Mohamad Tahir N, et al
    Characterization of Hemoglobin Malay Phenotypes in Tertiary Hospitals.
    Hemoglobin. 2024;48:153-160.
    >> Share

  4. SINGH R, Halder R, Hemant Gupta V, Rainchwar S, et al
    ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.
    Hemoglobin. 2024;48:186-191.
    >> Share

  5. YAO C, Chen L, Ma J, Li N, et al
    A Novel Frameshift Mutation of HBB Causing Dominant beta-Thalassemia in a Chinese Individual.
    Hemoglobin. 2024;48:182-185.
    >> Share

  6. BHATTACHARJEE S, Ghosh S, Shaw J, Bhattacharjee S, et al
    Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.
    Hemoglobin. 2024;48:161-168.
    >> Share

  7. ADEGOKE SA, Makalo L, Sallah A, Saine H, et al
    Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Hemoglobin. 2024;48:169-174.
    >> Share

  8. RAVICHANDRAN S, Hoffmann M, Petersen J, Sjo L, et al
    A Rare Case of De Novo Beta-Thalassemia Diagnosed by Whole-Genome Sequencing in an Ethnically Danish Newborn.
    Hemoglobin. 2024;48:196-199.
    >> Share

  9. IBRAHIM L, Gwarzo DH, Yusuf AA
    Secretory Phospholipase A2 Levels Are High in Women with Sickle Cell Disease and Menstruation-Induced Vaso-Occlusive Crises.
    Hemoglobin. 2024;48:175-181.
    >> Share

  10. HE X, Tian P, Zhong L, Peng S, et al
    A Novel 165 Kb Duplication Involving the alpha-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient.
    Hemoglobin. 2024;48:203-208.
    >> Share

  11. PAN L, Wang Y, Lin H, Zhang X, et al
    A Novel Frameshift Mutation(HBA2:C.337delC) Associated With alpha-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2024;48:200-202.
    >> Share

    April 2024
  12. KUMARI A, Chauhan G, Chaudhuri PK, Kumari S, et al
    Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis.
    Hemoglobin. 2024 Apr 18:1-12. doi: 10.1080/03630269.2024.2340685.
    >> Share

    March 2024
  13. LIU D, Nong X, Lai F, Nong C, et al
    Noninvasive Prenatal Diagnosis of SEA-Thalassemia by Combining 1000 Genomes Database and Relative Haplotype Dosage.
    Hemoglobin. 2024;48:71-78.
    >> Share

  14. VOUSVOUKI M, Delaki EE, Boutou E, Yfanti E, et al
    A New alpha1-Globin Variant, Hb Ormylia [HBA1:c.63C > G; p.His21Gln]. Report of Eleven Cases in Northern Greece.
    Hemoglobin. 2024;48:133-137.
    >> Share

  15. ASSAF N, El Zibaoui R, Monsef C, Abi Nassif T, et al
    Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two alpha-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.
    Hemoglobin. 2024;48:129-132.
    >> Share

  16. CHIN N, Asnani M
    Poor Sleep Quality in Jamaican Adults With Sickle Cell Disease: Prevalence, Risk Factors, and Association With Quality of Life.
    Hemoglobin. 2024;48:87-93.
    >> Share

  17. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    Newborn Screening for beta-Thalassemia Identifies a Complex Genotype Involving a Novel beta-Globin Gene Mutation (HBB:c.336dup).
    Hemoglobin. 2024;48:113-115.
    >> Share

  18. AL-ALLAWI N, Atroshi SD, Sadullah RK, Eissa AA, et al
    A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With beta-Thalassemia.
    Hemoglobin. 2024;48:94-100.
    >> Share

  19. WAYE JS, Hanna M, Nakamura L, Walker L, et al
    Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/beta(0)-Thalassemia.
    Hemoglobin. 2024;48:116-117.
    >> Share

    February 2024
  20. JIANG H, Li DZ
    Early Onset of Severe Anemia Caused by Hb Calgary (HBB: C.194G > T): Another Case Report.
    Hemoglobin. 2024 Feb 12:1-3. doi: 10.1080/03630269.2024.2315188.
    >> Share

    January 2024
  21. KHOSHNAW NSH, Omar JJ, Hussein ZS, Mohammed RN, et al
    Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
    Hemoglobin. 2024;48:56-59.
    >> Share

  22. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    beta(0)-Thalassemia Caused by a Novel Nonsense Mutation [HBB:c.199A > T].
    Hemoglobin. 2024;48:69-70.
    >> Share

  23. CHUANSUMRIT A, Songdej D, Sirachainan N, Kadegasem P, et al
    Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload.
    Hemoglobin. 2024;48:47-55.
    >> Share

  24. DESAI G, Dave K, Devare S, Desai S, et al
    Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease.
    Hemoglobin. 2024;48:66-68.
    >> Share

  25. WU SM, Li C, Huang SR, Jiang F, et al
    A 6-Year Follow-up of a Chinese Child with Homozygous beta(0)-Thalaasemia and a Heterozygous KLF1 Mutation.
    Hemoglobin. 2024;48:60-62.
    >> Share

  26. DE OLIVEIRA TAQUES W, Bett GC, de Moraes BLB, Medeiros I, et al
    Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study.
    Hemoglobin. 2024;48:39-46.
    >> Share

  27. MAMATA M, Padma G, Pragna Laxmi T, Saroja K, et al
    Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia.
    Hemoglobin. 2024;48:1-3.
    >> Share

  28. LADU AI, Kadaura MU, Dauda M, Baba AS, et al
    Malaria Infection in Patients with Sickle Cell Disease in Nigeria: Association with Markers of Hyposplenism.
    Hemoglobin. 2024;48:15-23.
    >> Share

  29. ZHENG LH, Liang L, Bai JP, Liao HX, et al
    Misdiagnosis of beta-Thalassemia Major Due to Chinese (G)gamma+((A)gammadeltabeta)(0)-Thalassemia Combined with beta(0)-Thalassemia.
    Hemoglobin. 2024;48:24-29.
    >> Share

  30. CHEN M, Lv A, Zhang S, Zheng J, et al
    First Report of Filipino beta(0)-Thalassemia/beta-Thalassemia in a Chinese Family.
    Hemoglobin. 2024;48:34-38.
    >> Share

    November 2023
  31. SILVA BORBOREMA T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R, et al
    Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Hemoglobin. 2023;47:85-96.
    >> Share

  32. SAEIDNIA M, Fazeli P, Farzi A, Atefy Nezhad M, et al
    An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
    Hemoglobin. 2023;47:56-70.
    >> Share

  33. QIU Y, Wei S, Hou W, Lai K, et al
    Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare beta-Globin Mutations.
    Hemoglobin. 2023;47:52-55.
    >> Share

  34. ARAUJO ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, et al
    Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
    Hemoglobin. 2023;47:71-79.
    >> Share

  35. TANG HS, Xiong Y, Li DZ
    Fetal Hemoglobin H Hydrops Fetalis: Another Three Case Reports.
    Hemoglobin. 2023;47:102-104.
    >> Share

  36. LIU D, Nong C, Lai F, Tang Y, et al
    Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia.
    Hemoglobin. 2023;47:80-84.
    >> Share

  37. WU BD, Zhou XY, Xie MJ, Jin CC, et al
    Identification of a Novel 7-bp Deletion in the alpha-Globin Gene Cluster in One Chinese Family.
    Hemoglobin. 2023;47:49-51.
    >> Share

  38. LONG J, Gong F, Sun L, Yu C, et al
    A novel alpha Globin Gene Cluster Duplication, alphaalphaalphaalpha(380) Heterozygous beta(0)-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype.
    Hemoglobin. 2023;47:25-30.
    >> Share

  39. DEMIDOVA E, Salomashkina V, Selivanova D, Litvin E, et al
    Hb Ryazan: An Elongated C-Terminal beta-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25.
    Hemoglobin. 2023;47:97-101.
    >> Share

  40. EGHBALI A, Ghaffari K, Shaykh Baygloo R, Eghbali A, et al
    Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
    Hemoglobin. 2023;47:42-48.
    >> Share

  41. SEYDEL GS, Ayan D, Balci T, Bayraktar M, et al
    Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.
    Hemoglobin. 2023;47:36-41.
    >> Share

  42. ZHANG W, Han X, Deng J, Zhou R, et al
    Two Novel alpha-Thalassemia Mutations CD 39 -C [Thr > Pro] and CD 109 ACC > CCC [Thr > Pro] Identified in Two Chinese Families: A Case Report.
    Hemoglobin. 2023;47:172-179.
    >> Share

  43. XIAO ZQ, Jiang F, Li DZ
    beta-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.
    Hemoglobin. 2023;47:145-146.
    >> Share

  44. HAJIMOHAMMADI Z, Alimohammadi-Bidhendi S, Bagheri Amiri F, Karimipoor M, et al
    Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions.
    Hemoglobin. 2023;47:163-166.
    >> Share

  45. KHATER D, Al-Mulaabed S, Alomairi A, Elshinawy M, et al
    Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose.
    Hemoglobin. 2023;47:157-162.
    >> Share

  46. 'ULYA NM, Indrawati VN, Wulansari WT, Lesmana I, et al
    Mutation Spectrum of beta-Globin Gene in Patients with beta-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
    Hemoglobin. 2023;47:152-156.
    >> Share

  47. YILDIRIM AT, Gulen H, Turkmen H, Ozek G, et al
    Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation.
    Hemoglobin. 2023;47:137-139.
    >> Share

  48. BAZAZZADEGAN N, Abedini SS, Azarkeivan A, Banihashemi S, et al
    The Spectrum of HBB Mutations among 2315 Beta Thalassemia Patients of a Reference Clinic in Tehran-Iran.
    Hemoglobin. 2023;47:147-151.
    >> Share

  49. BABU BV, Sharma Y, Sridevi P, Surti SB, et al
    Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Hemoglobin. 2023;47:227-236.
    >> Share

  50. HAMALI HA
    Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hemoglobin. 2023;47:205-214.
    >> Share

  51. MURAD H, Moassas F, Ali B, Katranji E, et al
    The Spectrum of alpha-Thalassemia Mutations in Syrian Patients.
    Hemoglobin. 2023;47:245-248.
    >> Share

  52. KEOWMANI T, Teo SC, Yap KC, Chua WL, et al
    Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study.
    Hemoglobin. 2023;47:237-244.
    >> Share

    September 2023
  53. GREWAL A, Kakkar S, Dewan P, Bansal N, et al
    Prevalence, Severity, and Determinants of Pain in Thalassemia.
    Hemoglobin. 2023;47:191-197.
    >> Share

  54. RASHID NW, Al-Allawi N, Tahir HI
    Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease.
    Hemoglobin. 2023;47:198-201.
    >> Share

  55. SINGH P, Shaikh S, Parmar S, Gupta R, et al
    Current Status of beta-Thalassemic Burden in India.
    Hemoglobin. 2023;47:181-190.
    >> Share

    July 2023
  56. ABU-ISMAIL L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, et al
    COVID-19 and Anemia: What Do We Know So Far?
    Hemoglobin. 2023 Jul 31:1-8. doi: 10.1080/03630269.2023.2236546.
    >> Share

    May 2023
  57. LIU L, Fu Q, Zhang D, Chen D, et al
    Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
    Hemoglobin. 2023 May 10:1-5. doi: 10.1080/03630269.2023.2206575.
    >> Share

  58. AL-ZEBARI S, Al-Allawi NA, Nerweyi F
    Beta Globin Gene Cluster Haplotypes in Beta Thalassemia in the Kurdistan Region of Iraq.
    Hemoglobin. 2023;47:111-117.
    >> Share

  59. SHAMOON R, Yassin A, Charkaneh A
    Detection of a Rare Mutation in the Initiation Codon of the beta-Globin Gene (HBB:C.2T > C; P.Met1Thr).
    Hemoglobin. 2023;47:118-121.
    >> Share

  60. CHEN YP, Wu P, Wang H, Wu JF, et al
    A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C beta 68(E12) Leu-Pro]: A First Report in the Chinese Population.
    Hemoglobin. 2023;47:130-134.
    >> Share

  61. KUMAR R, Ahmad SA, Ozdemir M, Sadayappan S, et al
    Mutation Spectrum of beta-Thalassemia in Some Ethnic Groups of North Maharashtra, India.
    Hemoglobin. 2023;47:105-110.
    >> Share

    January 2023
  62. PUROHIT P, Mohanty PK, Panigrahi J, Das K, et al
    Effect of alpha(+) Thalassemia on the Severity of Plasmodium falciparum Malaria in Different Sickle Cell Genotypes in Indian Adults: A Hospital-Based Study.
    Hemoglobin. 2023;47:11-18.
    >> Share

  63. KABIR T, Anwar S, Mourosi JT, Akter S, et al
    alpha- and beta-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh.
    Hemoglobin. 2023;47:3-10.
    >> Share

  64. PAN L, Tian P, Chen S, Zhang R, et al
    Novel Promoter Mutation (HBB:C.-139_-138del) Associated with beta-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2023;47:21-24.
    >> Share

    November 2022
  65. WEN YJ, Yu QX, Jiang F, Li DZ, et al
    Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
    Hemoglobin. 2022;46:347-350.
    >> Share

  66. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
    Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
    Hemoglobin. 2022;46:297-302.
    >> Share

  67. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
    Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
    Hemoglobin. 2022;46:308-311.
    >> Share

  68. WU SM, Huang SR, Li C, Chen GL, et al
    Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
    Hemoglobin. 2022;46:341-343.
    >> Share

  69. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
    Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
    Hemoglobin. 2022;46:317-324.
    >> Share

  70. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
    Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
    Hemoglobin. 2022;46:303-307.
    >> Share

  71. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
    A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
    Hemoglobin. 2022;46:338-340.
    Lys; HBB: c.22G>A] and Hb H Disease.&body=GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al. A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease. Hemoglobin. 2022;46:338-340. https://www.ncbi.nlm.nih.gov/m/pubmed/36691989" ALT="Email" TITLE="Email"> --> >> Share

  72. LONG J, Gong F, Sun L, Lai G, et al
    Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
    Hemoglobin. 2022;46:325-329.
    >> Share

    September 2022
  73. YIN ZZ, Yao J, Wei FX, Chen CY, et al
    Targeted Next-Generation Sequencing Reveals a Large Novel beta-Thalassemia Deletion that Removes the Entire HBB Gene.
    Hemoglobin. 2022;46:290-295.
    >> Share

  74. VACHHANI NA, Vekariya DJ, Colah RB, Kashiyani HN, et al
    Spectrum of beta-Thalassemia and Other Hemoglobinopathies in the Saurashtra Region of Gujarat, India: Analysis of a Large Population Screening Program.
    Hemoglobin. 2022;46:285-289.
    >> Share

  75. WANG K, Yi T, Wu WT, Lu J, et al
    Investigation of the Distribution of Thalassemia in Children in Jiangxi Province, the People's Republic of China.
    Hemoglobin. 2022;46:272-276.
    >> Share

    August 2022
  76. AMARASINGHA AADS, Silva HJRL, Perera PS, Premawardhena AP, et al
    Anemia in Sri Lanka: A Literature Review.
    Hemoglobin. 2022 Aug 24:1-11. doi: 10.1080/03630269.2022.2096460.
    >> Share

    July 2022
  77. BAO XQ, Wang JC, Qin DQ, Yao CZ, et al
    A Novel 5 kb Deletion in the beta-Globin Gene Cluster Identified in a Chinese Patient.
    Hemoglobin. 2022;46:245-248.
    >> Share

  78. WARANG PP, Shinde NS, Umare VD, Deshmukh PV, et al
    Role of Oxidative Stress and the Protective Effect of Fermented Papaya Preparation in Sickle Cell Disease.
    Hemoglobin. 2022;46:260-264.
    >> Share

  79. FARMAKIS D, Angastiniotis M, El Ghoul MM, Cannon L, et al
    Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation.
    Hemoglobin. 2022;46:225-232.
    >> Share

  80. LAM TT, Nguyen DT, Le QT, Nguyen DA, et al
    Combined Gap-Polymerase Chain Reaction and Targeted Next-Generation Sequencing Improve alpha- and beta-Thalassemia Carrier Screening in Pregnant Women in Vietnam.
    Hemoglobin. 2022;46:233-239.
    >> Share

  81. LOCKE M, Reddy PS, Badawy SM
    Adherence to Iron Chelation Therapy among Adults with Thalassemia: A Systematic Review.
    Hemoglobin. 2022;46:201-213.
    >> Share

  82. LIN XM, Jiang F, Li J, Li DZ, et al
    Dominantly Inherited beta-Thalassemia Caused by a Single Nucleotide Deletion in Exon 3 of the beta-Globin Gene: Hb Xiangyang (HBB: c.393delT).
    Hemoglobin. 2022;46:253-255.
    >> Share

  83. SEN A, Sen A, Dolai TK
    Diagnostic Dilemma of Hemoglobinopathies Using High Performance Liquid Chromatography Alone: A Case Report from a Resource-Constrained Setting.
    Hemoglobin. 2022;46:256-259.
    >> Share

  84. LIAO J, Li Q, Ling LQ, Liu CN, et al
    A Triple-Heterozygous beta-Thalassemia Patient Demonstrated an Unusual Electrophoresis Pattern Due to a Novel beta(0) Mutation [an IVS-II-654 (C>T) mutation with a Hb Zurich-Langstrasse (HBB: c.151A>T) mutation in cis].
    Hemoglobin. 2022;46:249-252.
    >> Share

  85. ZHANG L, Bao LJ, Hong ZD, Yan MX, et al
    Dysregulated Serum Cytokine Production in Pediatric Patients with beta-Thalassemia Major.
    Hemoglobin. 2022;46:191-196.
    >> Share

    May 2022
  86. MANCO L, Santos R, Rocha C, Relvas L, et al
    Hb F Levels in beta-Thalassemia Carriers and Normal Individuals: Known and Unknown Quantitative Trait Loci in the beta-Globin Gene Cluster.
    Hemoglobin. 2022;46:168-175.
    >> Share

  87. REN ZM, Xing ZH, Chen SL, Fu XY, et al
    Identification of a Novel Hb H Disease with Glucose-6-Phosphate Dehydrogenase Deficiency Using Whole Genome Sequencing.
    Hemoglobin. 2022;46:160-163.
    >> Share

  88. KURUCU B, Fettah A, Capkinoglu E, Oner N, et al
    Dynamic Thiol-Disulfide Homeostasis in Children With beta-Thalassemia Trait.
    Hemoglobin. 2022;46:164-167.
    >> Share

  89. KHAMPHIKHAM P, Sakkhachornphop S, Pongsatha S, Pornprasert S, et al
    Strong Positive Dichlorophenolindophenol Precipitation Suggests Hb Dhonburi (or Hb Neapolis) (HBB: c.380T>G) Inheritance in a Couple at Risk for Severe beta-Thalassemia.
    Hemoglobin. 2022;46:184-186.
    >> Share

  90. PARSASEFAT M, Safarpour H, Nomiri S, Miri-Moghaddam E, et al
    Treatment with Hydroxyurea Leads to Fetal Hemoglobin Reactivation through CA1 and LIN28B Genes: An In Vitro Study.
    Hemoglobin. 2022;46:153-159.
    >> Share

  91. MORADI K, Aznab M, Azimi A, Biglari M, et al
    alpha-Thalassemia Mutations in Ilam Province, West Iran.
    Hemoglobin. 2022;46:147-152.
    >> Share

    March 2022
  92. VARELAS C, Gavriilaki E, Sakellari I, Klonizakis F, et al
    Hemoglobinopathies and COVID-19: The Experience of a Center in Northern Greece.
    Hemoglobin. 2022;46:143-145.
    >> Share

  93. MANGANAS K, Delicou S, Xydaki A, Koskinas J, et al
    Iron Chelators, Such as Deferasirox, When Combined With Hydroxyurea, Provide an Additional Benefit of Iron Chelation in Patients Receiving Chronic Transfusion Therapy.
    Hemoglobin. 2022;46:114-117.
    >> Share

  94. ZARKADA E, Yfanti E, Teli A, Balassopoulou A, et al
    Rare Pathogenic beta(0)-Thalassemia Mutation, Codon 7 (GAG>TAG) (HBB: c.22G>T). Report of the First Two Cases in Albanian Immigrants of Northern Greece.
    Hemoglobin. 2022;46:140-142.
    >> Share

  95. SAHA D, Chowdhury PK, Panja A, Pal D, et al
    Effect of deletions in the alpha-globin gene on the phenotype severity of beta-thalassemia.
    Hemoglobin. 2022;46:118-123.
    >> Share

  96. EFSTATHIOU A, Boutou E, Teli A, Drikos I, et al
    A New Hemoglobin Variant, Hb Natal (HBA1: c.423C>A), Found in a Greek Family.
    Hemoglobin. 2022;46:132-136.
    >> Share

  97. KITTIPOOM T, Tantiworawit A, Punnachet T, Hantrakun N, et al
    The Long-Term Efficacy of Deferiprone in Thalassemia Patients With Iron Overload: Real-World Data from the Registry Database.
    Hemoglobin. 2022;46:75-80.
    >> Share

  98. JIANG F, Chen GL, Li J, Tang XW, et al
    beta-Thalassemia Intermedia Caused by the beta-Globin Gene 3' Untranslated Region: Another Case Report.
    Hemoglobin. 2022;46:137-139.
    >> Share

  99. KARAKAYA T, Silan F, Ozdemir O
    A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.
    Hemoglobin. 2022;46:87-90.
    Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels.&body=KARAKAYA T, Silan F, Ozdemir O. A New Mutation, Hb A2-Canakkale [delta10(A7)Ala-->Val; HBD: c.32C>T], and Other Well-Known delta Variants Identified in a Selected Cohort with Low Hb A2 Levels. Hemoglobin. 2022;46:87-90. https://www.ncbi.nlm.nih.gov/m/pubmed/35930292" ALT="Email" TITLE="Email"> --> >> Share

  100. ZAMAN BA, Ibrahim SA
    Hepcidin-to-Ferritin Ratio as an Early Diagnostic Index of Iron Overload in beta-Thalassemia Major Patients.
    Hemoglobin. 2022;46:106-113.
    >> Share

  101. BICILIOGLU Y, Bal A, Demir Yenigurbuz F, Ergonul E, et al
    Noninvasive Hemoglobin Measurement Reduce Invasive Procedures in Thalassemia Patients.
    Hemoglobin. 2022;46:95-99.
    >> Share

  102. BINDING A
    Bringing Sickle Cell Disease Care Closer to Home: Feasibility and Efficacy of a Quality Improvement Initiative at a Community Hospital.
    Hemoglobin. 2022;46:91-94.
    >> Share

    January 2022
  103. PAIBOONSUKWONG K, Jopang Y, Winichagoon P, Fucharoen S, et al
    Thalassemia in Thailand.
    Hemoglobin. 2022;46:53-57.
    >> Share

  104. CHONG SC, Metassan S, Yusof N, Idros R, et al
    Thalassemia in Asia 2021 Thalassemia in Brunei Darussalam.
    Hemoglobin. 2022;46:15-19.
    >> Share

  105. KHAING AA, Myint PP, Paiboonsukwong K, Win N, et al
    Clinical Severity of beta-Thalassemia Pediatric Patients in Myanmar.
    Hemoglobin. 2022;46:66-70.
    >> Share

  106. COLAH RB, Seth T
    Thalassemia in India.
    Hemoglobin. 2022;46:20-26.
    >> Share

  107. PREMAWARDHENA AP, Madushanka HDP
    Thalassemia in Sri Lanka.
    Hemoglobin. 2022;46:71-73.
    >> Share

  108. CHOWDHURY MA, Sultana R, Das D
    Thalassemia in Asia 2021 Overview of Thalassemia and Hemoglobinopathies in Bangladesh.
    Hemoglobin. 2022;46:7-9.
    >> Share

  109. SOPHAL C
    Thalassemia Status in Cambodia.
    Hemoglobin. 2022;46:10-11.
    >> Share

  110. FUCHAROEN S, Ping C, Paiboonsukwong K
    Introduction to the Special Issue.
    Hemoglobin. 2022;46:1.
    >> Share

  111. KHALIQ S
    Thalassemia in Pakistan.
    Hemoglobin. 2022;46:12-14.
    >> Share

  112. YUSON ED, Naranjo MLT
    Thalassemia in the Philippines.
    Hemoglobin. 2022;46:36-38.
    >> Share

  113. WAHIDIYAT PA, Sari TT, Rahmartani LD, Iskandar SD, et al
    Thalassemia in Indonesia.
    Hemoglobin. 2022;46:39-44.
    >> Share

  114. PHENGSAVANH A, Sengchanh S, Souksakhone C, Souvanlasy B, et al
    Current Status of Thalassemia in Lao People's Democratic Republic.
    Hemoglobin. 2022;46:58-61.
    >> Share

  115. BACH KQ, Nguyen HTT, Nguyen TH, Nguyen MB, et al
    Thalassemia in Viet Nam.
    Hemoglobin. 2022;46:62-65.
    >> Share

  116. ALWI ZB, Syed-Hassan SR
    Thalassemia in Malaysia.
    Hemoglobin. 2022;46:45-52.
    >> Share

  117. CHEN P, Lin WX, Li SQ
    THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People's Republic of China.
    Hemoglobin. 2022;46:33-35.
    >> Share

  118. ANURATHAPAN U, Pakakasama S, Songdej D, Pongphitcha P, et al
    Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
    Hemoglobin. 2022;46:2-6.
    >> Share

  119. YADAV SS, Panchal P, Menon KC
    Prevalence and Management of beta-Thalassemia in India.
    Hemoglobin. 2022;46:27-32.
    >> Share

    November 2021
  120. MELVIN RG, Liederman Z, Arya S, Rotin L, et al
    A Case of Fat Embolism Syndrome with Cerebral Involvement in Sickle Cell Anemia.
    Hemoglobin. 2021 Nov 8:1-5. doi: 10.1080/03630269.2021.1990081.
    >> Share

  121. DEHURY S, Mohanty PK, Patel S, Meher S, et al
    Profiling of 35 Cases of Hb S/Hb E (HBB: c.20A>T/HBB: c.79G>a), Disease and Association with alpha-Thalassemia and beta-Globin Gene Cluster Haplotypes from Odisha, India.
    Hemoglobin. 2021;45:380-386.
    >> Share

  122. CHAN NCN, Wong THY, Cheng KCK, Chan NPH, et al
    An Evaluation for the Causes of Reduced Hb A2 and the Molecular Characterization of HBD Variants in Hong Kong.
    Hemoglobin. 2021;45:387-391.
    >> Share

  123. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    Incidence Rate of COVID-19 Infection in Hemoglobinopathies: A Systematic Review and Meta-analysis.
    Hemoglobin. 2021;45:371-379.
    >> Share

  124. FARRA C, Abdouni L, Souaid M, Awwad J, et al
    The Spectrum of beta-Thalassemia Mutations in the Population Migration in Lebanon: A 6-Year Retrospective Study.
    Hemoglobin. 2021;45:365-370.
    >> Share

  125. TSITSIKAS DA, Kamal M, Braimoh A, Benson S, et al
    Hb S (HBB: c.20A>T) Characteristics by High Performance Liquid Chromatography in Patients with Sickle Cell Disease Receiving the Novel Agent Voxelotor.
    Hemoglobin. 2021;45:355-357.
    >> Share

  126. ALIYEVA G, Abdulalimov E, Asadov C, Mammadova T, et al
    First Report of beta-Thalassemia Intermedia in a Patient Compound Heterozygous for -92 (C>T) and Codons 36/37 (-T) Mutations.
    Hemoglobin. 2021;45:347-348.
    >> Share

    September 2021
  127. HUANG LF, Yu LL, Nikuze L, Singh S, et al
    Spectrum of beta-Thalassemia Mutations in Some Areas of Guangxi Zhuang Autonomous Region of Southern China: A Study on a Pediatric Population Aged 0-15 Years.
    Hemoglobin. 2021;45:318-321.
    >> Share

  128. HAMALI HA
    Glucose-6-Phosphate Dehydrogenase Deficiency: An Overview of the Prevalence and Genetic Variants in Saudi Arabia.
    Hemoglobin. 2021;45:287-295.
    >> Share

  129. YADAV DD, Jamwal M, Singh N, Sharma R, et al
    Hb Mizuho (HBB: c.206T>C): Pitfalls of Screening Tests in an Unstable Hemoglobin Variant Diagnosed after Targeted Next-Generation Sequencing.
    Hemoglobin. 2021;45:338-340.
    >> Share

  130. RUENGDIT C, Punyamung M, Khamphikham P, Pongpunyayuen P, et al
    Multiplex Quantitative Real-Time Polymerase Chain Reaction and High-Resolution Melting Analysis for Identification of a Couple At-Risk of Having a Newborn with Severe Thalassemia.
    Hemoglobin. 2021;45:309-313.
    >> Share

  131. TRUTTMANN R, Schmidt A, Hartmann B, Rusch S, et al
    Description of Hb Evora (HBA2: c.106T>C) on an Unexpected Allele in a Swiss Family.
    Hemoglobin. 2021;45:314-317.
    >> Share

  132. ZAHRA A, Ragab A, Al-Abboh H, Ismaiel A, et al
    Perforated Duodenal Ulcer Associated with Deferasirox in a Child with beta-Thalassemia Major.
    Hemoglobin. 2021;45:335-337.
    >> Share

  133. CHEN HQ, Wu LS, Jiang F, Li DZ, et al
    Dominant beta-Thalassemia Phenotype Caused by Hb Dieppe (HBB: c.383A>G): Another Case Report.
    Hemoglobin. 2021;45:329-331.
    >> Share

  134. SEN A, Seenappa V, Chakrabarti P, Dolai TK, et al
    First Report of the 3'-Untranslated Region +1506 (A>C) [NM_000518.5: c.*32A>C] mutation on the beta-Globin Gene in the Indian Population.
    Hemoglobin. 2021;45:325-328.
    >> Share

  135. DELICOU S, Aggeli K, Magganas K, Patsourakos D, et al
    Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Outcomes. The Experience of a Single Thalassemia and Sickle Cell Unit in a University Hospital.
    Hemoglobin. 2021;45:303-308.
    >> Share

  136. HAGHPANAH S, Hosseini-Bensenjan M, Sayadi M, Karimi M, et al
    The Prevalence of Hypothyroidism among Patients With beta-Thalassemia: A Systematic Review and Meta-Analysis of Cross-Sectional Studies.
    Hemoglobin. 2021;45:275-286.
    >> Share

  137. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eleven Cases of Hb J-Paris-I [HBA2: c.38C>A (or HBA1)]: A Stable alpha Chain Variant Elutes in the P3 Window on High-Performance Liquid Chromatography.
    Hemoglobin. 2021;45:322-324.
    >> Share

  138. TRIPATHY I, Panja A, Dolai TK, Mallick AK, et al
    Comparative Efficacy and Safety Between Deferiprone and Deferasirox with Special Reference to Serum Ferritin Level and Cardiac Function in Bengali beta-Thalassemia Major Children.
    Hemoglobin. 2021;45:296-302.
    >> Share

    July 2021
  139. ATROSHI SD, Al-Allawi NAS, Eissa AA
    Updated Molecular Spectrum of beta-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration.
    Hemoglobin. 2021;45:239-244.
    >> Share

  140. PERERA S, Allen A, Rees DC, Premawardhena A, et al
    Pitfalls in the Diagnosis of beta-Thalassemia Intermedia.
    Hemoglobin. 2021;45:265-268.
    >> Share

  141. KHALIL MSM, Timbs AT, Henderson SJ, Schuh A, et al
    Eight Cases of Hb Winnipeg [HBA2: c.226G>T (or HBA1)]: A Detailed Study.
    Hemoglobin. 2021;45:256-258.
    >> Share

  142. ETEMAD K, Mohseni P, Aghighi M, Bahadorimonfared A, et al
    Quality of Life and Related Factors in beta-Thalassemia Patients.
    Hemoglobin. 2021;45:245-249.
    >> Share

  143. UCUCU S, Karabiyik T, Azik FM
    IVS-II-16 (G>C) (HBB: c.315+16G>C) or IVS-II-666 (C>T) (HBB: c.316-185C>T) Mutations Trigger an Hb S (HBB: c.20A>T)/beta(+)-Thalassemia Phenotype in an Hb S Trait Patient.
    Hemoglobin. 2021;45:225-227.
    >> Share

  144. IDRIS IM, Yusuf AA, Gwarzo DH, Kurawa MS, et al
    High Systolic Blood Pressure, Anterior Segment Changes and Visual Impairment Independently Predict Sickle Cell Retinopathy.
    Hemoglobin. 2021;45:228-233.
    >> Share

  145. MARTIN G, Grimholt RM, Le D, Bechensteen AG, et al
    Hb Calgary (HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a beta-Thalassemia Major Phenotype.
    Hemoglobin. 2021;45:215-219.
    >> Share

  146. RAFAT M, Allamehzadeh Z, Shekari M, Afsa M, et al
    The Effect of HBB: c.-121C>T Variant [-71 (C>T)] on the beta-Globin Promoter: Case Series Study.
    Hemoglobin. 2021;45:234-238.
    >> Share

  147. JIANG F, Tang XW, Li J, Zhou JY, et al
    Hb Lepore-Hong Kong: First Report of a Novel delta/beta-Globin Gene Fusion in a Chinese Family.
    Hemoglobin. 2021;45:220-224.
    >> Share

    June 2021
  148. ANAH MU, Nlemadim AC, Uzomba CI, Ineji EO, et al
    Prolonged QTc Interval in Nigerian Children with Sickle Cell Anemia.
    Hemoglobin. 2021 Jun 10:1-6. doi: 10.1080/03630269.2021.1937207.
    >> Share

    May 2021
  149. ZHAO Q, Zhao SM, Zhang X, Chen SP, et al
    Detection of the HBB: c.393T>G Mutation in Two Patients with Hypochromic Microcytic Anemia.
    Hemoglobin. 2021 May 25:1-4. doi: 10.1080/03630269.2021.1929307.
    >> Share

  150. BROWN BJ, Madu A, Sangeda RZ, Nkya S, et al
    Utilization of Pneumococcal Vaccine and Penicillin Prophylaxis in Sickle Cell Disease in Three African Countries: Assessment among Healthcare Providers in SickleInAfrica.
    Hemoglobin. 2021;45:163-170.
    >> Share

  151. TSOLAKIDIS V, Vlachaki E, Papaioannou M, Pantelidou D, et al
    Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece.
    Hemoglobin. 2021;45:143-149.
    >> Share

  152. MOORE JA, Pullon BM, Wang D, Brennan SO, et al
    Hb Tacoma: G>T or G>C, and Does It Matter?
    Hemoglobin. 2021;45:203-206.
    >> Share

  153. SOOD R, Rastogi P, Bansal D, Das R, et al
    An Autopsy Case of beta-Thalassemia Major Illuminating the Pathological Spectrum of the Disease.
    Hemoglobin. 2021;45:180-185.
    >> Share

  154. ATROSHI SD, Al-Allawi N, Chui DHK, Najmabadi H, et al
    A Novel beta(0)-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd.
    Hemoglobin. 2021;45:212-214.
    >> Share

  155. SAENSUWANNA A, Penglong T, Srinoun K
    Upregulation of miR-214 Mediates Oxidative Stress in Hb H Disease via Targeting of ATF4.
    Hemoglobin. 2021;45:197-202.
    >> Share

  156. RUJEERAPAIBOON N, Tantiworawit A, Piriyakhuntorn P, Rattanathammethee T, et al
    Correlation Between Serum Ferritin and Viral Hepatitis in Thalassemia Patients.
    Hemoglobin. 2021;45:175-179.
    >> Share

  157. THEPPORNPITAK K, Trakarnsanga B, Lauhasurayotin S, Poparn H, et al
    A Study to Assess and Improve Adherence to Iron Chelation Therapy in Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2021;45:171-174.
    >> Share

  158. LUO LP, Ma L, Lin SB, Huang JG, et al
    Elevated Hb A2 is Not Always Indicative of beta-Thalassemia.
    Hemoglobin. 2021;45:186-190.
    >> Share

  159. SAHA J, Panja A, Nayek K
    The Prevalence of HBB Mutations among the Transfusion-Dependent and Non Transfusion-Dependent Hb E/beta-Thalassemia Children in a Tertiary Center of West Bengal, India.
    Hemoglobin. 2021;45:157-162.
    >> Share

  160. TIAN Q, Lei YL, Xu LL, Li DZ, et al
    First Report of Nondeletional Hb H Disease Caused by an alpha2-Globin Gene Mutation: HBA2: c.184A>T.
    Hemoglobin. 2021;45:210-211.
    >> Share

    March 2021
  161. ALIMOHAMMADI-BIDHENDI S, Azadmehr S, Razipour M, Zeinali S, et al
    Regulatory Mutation Study in Cases with Unsolved Hypochromic Microcytic Anemia and alpha-Major Regulatory Element Haplotype Analysis in Iran.
    Hemoglobin. 2021 Mar 27:1-4. doi: 10.1080/03630269.2021.1882482.
    >> Share

  162. OGU UO, Reyes Gil M, Tolu SS, Acharya SA, et al
    First Report of Compound Heterozygosity for Hb S (HBB: c.20A>T) and Hb Haringey (HBB: c.131A>G).
    Hemoglobin. 2021;45:136-139.
    >> Share

  163. YIN Z, Hao Y, Huang X, Chen X, et al
    A Novel Mutation at HBA1: c.349G>T Causing alpha-Thalassemia in a Chinese Family.
    Hemoglobin. 2021;45:94-96.
    >> Share

  164. MARTINEZ VILLEGAS O, Mendoza-Melendez D, Trueba-Gomez R, Rosenfeld-Mann F, et al
    Analysis of a Novel Mexican Variant of the HBB Gene Associated with beta-Thalassemia Using Bioinformatic Tools.
    Hemoglobin. 2021;45:87-93.
    >> Share

  165. INATI A, Al Alam C, El Ojaimi C, Hamad T, et al
    Clinical Features and Outcome of Sickle Cell Disease in a Tertiary Center in Northern Lebanon: A Retrospective Cohort Study in a Local, Hospital-Associated Registry.
    Hemoglobin. 2021;45:80-86.
    >> Share

  166. PANICHCHOB P, Iamdeelert P, Wongsariya P, Wongsariya P, et al
    Molecular Spectrum of beta-Thalassemia Mutations in Central to Eastern Thailand.
    Hemoglobin. 2021;45:97-102.
    >> Share

  167. SHARIFI F, Safizadeh H, Bahrampour A
    Development of the Quality of Life Questionnaire (SF-36) for Patients with beta-Thalassemia Major and beta-Thalassemia Intermedia Based on Extended Rasch Analysis.
    Hemoglobin. 2021;45:119-123.
    >> Share

  168. ZARDKHONI SZ, Moghaddam AG, Rad F, Ghatee MA, et al
    Serum Zinc Level in beta-Thalassemia Major: A Retrospective Study in Southwest Iran.
    Hemoglobin. 2021;45:103-106.
    >> Share

  169. ZHAO YL, Lin QF, He XW, Li YQ, et al
    Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.
    Hemoglobin. 2021;45:133-135.
    Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene.&body=ZHAO YL, Lin QF, He XW, Li YQ, et al. Hb Hezhou [beta64(E8)Gly-->Ser; HBB: c.193G>A]: A Novel Variant on the beta-Globin Gene. Hemoglobin. 2021;45:133-135. https://www.ncbi.nlm.nih.gov/m/pubmed/33843396" ALT="Email" TITLE="Email"> --> >> Share

  170. SOLTANI D, Fakhrzadeh H, Sharifi F, Mahmoudi MJ, et al
    Surrogate Markers of Subclinical Atherosclerosis and Its Associated Factors in Patients with beta-Thalassemia Major.
    Hemoglobin. 2021;45:107-111.
    >> Share

  171. COLAH RB, Nadkarni AH, Gorakshakar AC, Sawant PM, et al
    The Changing Trends in Prenatal Diagnosis of Hemoglobinopathies in India: The Quest of a Single Center to Reduce the Burden of Disease over Three Decades.
    Hemoglobin. 2021;45:112-118.
    >> Share

  172. RUENGDIT C, Khamphikham P, Jinorose N, Pornprasert S, et al
    Hb Bart's Hydrops Fetalis Syndrome and Hb H Disease Caused by Deletional Chiang Rai (- -(CR)) alpha(0)-Thalassemia in Two Unrelated Thai Families.
    Hemoglobin. 2021;45:75-79.
    >> Share

  173. WANG RY, Jiang F, Xu LL, Li DZ, et al
    Mild alpha-Thalassemia Caused by a Mosaic alpha-Globin Gene Mutation.
    Hemoglobin. 2021;45:140-141.
    >> Share

    January 2021
  174. MEHER S, Mohanty PK, Patel S, Das K, et al
    Haptoglobin Genotypes Associated with Vaso-Occlusive Crisis in Sickle Cell Anemia Patients of Eastern India.
    Hemoglobin. 2021 Jan 3:1-7. doi: 10.1080/03630269.2020.1801459.
    >> Share

  175. ZAFARI M, Rad MTS, Mohseni F, Nikbakht N, et al
    beta-Thalassemia Major and Coronavirus-19, Mortality and Morbidity: a Systematic Review Study.
    Hemoglobin. 2021;45:1-4.
    >> Share

  176. CHEN X, Lin Z, Hu J, Chen S, et al
    Report of Two Novel Thalassemia Variants, HBB: c.181delG and HBA1: c.121_126delAAGACC, in Chinese Individuals.
    Hemoglobin. 2021;45:52-55.
    >> Share

  177. LIU L, Sun Y, Chen S, Yu C, et al
    Identification of Two Novel Thalassemia Variants, HBA1: c.263delA and HBA2: c.376dupC, in Chinese Individuals.
    Hemoglobin. 2021;45:49-51.
    >> Share

  178. AL-ZUHAIRY SH, Darweesh MA, Othman MA
    Relation of Serum Ferritin Level with Serum Hepcidin and Fucose Levels in Children with beta-Thalassemia Major.
    Hemoglobin. 2021;45:69-73.
    >> Share

  179. BALLAS SK, Riddick-Burden G, Congdon-Martin E
    Determinants of the Outcome of the Transition of Children with Sickle Cell Disease to Adult Programs.
    Hemoglobin. 2021;45:62-65.
    >> Share

  180. TARIQ A, Khurshid S, Sajjad M
    Evaluation of the High Resolution Melting Approach for Detection of beta-Thalassemia Gene Mutations.
    Hemoglobin. 2021;45:20-24.
    >> Share

  181. LIN QY, Chen DY, Kong S, Liu WQ, et al
    A Rare Case of Hb H Disease and Systemic Lupus Erythematosus.
    Hemoglobin. 2021;45:66-68.
    >> Share

  182. WANG WJ, Ding ZX, Zhang HM, Tao TT, et al
    Identification of a Novel beta-Thalassemia Mutation at Codon 130 (+T) (HBB: c.391insT) in Han Chinese.
    Hemoglobin. 2021;45:46-48.
    >> Share

  183. GOLLAMUDI J, Sarvepalli S, Vadaparti Binf A, Alin T, et al
    Venous Thromboembolism in Sickle Cell Disease is Associated with Neutrophilia.
    Hemoglobin. 2021;45:56-59.
    >> Share

  184. SIGAL IR, Ciunci CA
    Case Report of Acute Splenic Sequestration Crisis in an Adult Patient with Hb S Disease and Suspected Hereditary Persistence of Fetal Hemoglobin.
    Hemoglobin. 2021;45:60-61.
    >> Share

  185. DOULGERAKI A, Fragodimitri C, Athanasopoulou H, Drakaki K, et al
    Chronic Hemolysis May Adversely Affect Skeletal Health. A Cross-Sectional Study of a Pediatric Population.
    Hemoglobin. 2021;45:30-36.
    >> Share

  186. AYDOGDU S, Toret E, Aksoy BA, Aydin MF, et al
    Comparison of Hematopoietic Stem Cell Transplantation Results in Patients with beta-Thalassemia Major from Three Different Graft Types.
    Hemoglobin. 2021;45:25-29.
    >> Share

  187. ANGASTINIOTIS M, Petrou M, Loukopoulos D, Modell B, et al
    The Prevention of Thalassemia Revisited: A Historical and Ethical Perspective by the Thalassemia International Federation.
    Hemoglobin. 2021;45:5-12.
    >> Share

  188. LIEDERMAN Z, Quartey NK, Ward R, Papadakos J, et al
    Exploration of Barriers and Facilitators to Optimal Emergency Department Care of Sickle Cell Disease: Opportunities for Patient-Physician Partnerships to Improve Care.
    Hemoglobin. 2021;45:13-19.
    >> Share

    November 2020
  189. CHOURASIA S, Kumar R, Singh MPSS, Vishwakarma C, et al
    High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India.
    Hemoglobin. 2020 Nov 22:1-10. doi: 10.1080/03630269.2020.1848859.
    >> Share

    July 2020
  190. BALANCHIVADZE N, Kudirka AA, Askar S, Almadhoun K, et al
    Impact of COVID-19 Infection on 24 Patients with Sickle Cell Disease. One Center Urban Experience, Detroit, MI, USA.
    Hemoglobin. 2020;44:284-289.
    >> Share

    March 2020
  191. TERAN MM, Monaco ME, Lazarte SS, Haro C, et al
    Genetic Regulation of Redox Balance in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:122-127.
    >> Share

  192. AL-ALI AK, Alsulaiman A, Alzahrani AJ, Obeid OT, et al
    Prevalence and Diversity of Haplotypes of Sickle Cell Disease in the Eastern Province of Saudi Arabia.
    Hemoglobin. 2020;44:78-81.
    >> Share

  193. AZIMI A, Tahmasebi S, Moradi K, Nejati P, et al
    Severe alpha-Thalassemia Due to Compound Heterozygosity for Hb Adana (alpha59 Gly>Asp) (HBA1: c.179G > A) and Codon 127 (A > T) (HBA2: c.382A > T) in an Iranian Family.
    Hemoglobin. 2020;44:139-142.
    >> Share

  194. HORRI-NACEUR A, Timson DJ
    In Silico Analysis of the Effects of Point Mutations on alpha-Globin: Implications for alpha-Thalassemia.
    Hemoglobin. 2020;44:89-103.
    >> Share

  195. SAMHA L, Sirdah MM, Reading NS, Karmi B, et al
    Molecular Understanding of Severe Cases of beta-Thalassemia in the Nablus Region, West Bank, Palestine.
    Hemoglobin. 2020;44:128-130.
    >> Share

  196. AKSU T, Coskun C, Kuskonmaz B, Unal S, et al
    Hb H Disease Diagnosed During Adolescent Pregnancy.
    Hemoglobin. 2020;44:137-138.
    >> Share

  197. AZARKEIVAN A, Cohan N, Niazkar HR, Azizi A, et al
    Hb S (HBB: c.20A>T) and alpha- and beta-Thalassemia Coinheritance in Iranian Patients.
    Hemoglobin. 2020;44:109-112.
    >> Share

  198. HALDER R, Sundaram UKD, Veetil KK, Rath A, et al
    Concomitant Existence of Paroxysmal Nocturnal Hemoglobinuria in a Patient with Hb E (HBB: c.79G>A) Trait.
    Hemoglobin. 2020;44:134-136.
    >> Share

  199. JIANG F, Xu LL, Chen GL, Zhou JY, et al
    Hematological Characteristics of Hb Constant Spring (HBA2: c.427T>C) Carriers in Mainland China.
    Hemoglobin. 2020;44:86-88.
    >> Share

  200. MANCO L, Bento C, Relvas L, Cunha E, et al
    Multi-Locus Models to Address Hb F Variability in Portuguese beta-Thalassemia Carriers.
    Hemoglobin. 2020;44:113-117.
    >> Share

  201. AL-NOOD HA, Al-Nood RM, Ghanem NS, Al-Hadi AM, et al
    Effect of the Hydoxyurea in Yemeni Transfusion-Dependent beta-Thalassemia Patients.
    Hemoglobin. 2020;44:104-108.
    >> Share

  202. ALASHKAR F, Herbstreit F, Carpinteiro A, Baum J, et al
    Veno-Venous Extracorporeal Membrane Oxygenation in Adult Patients with Sickle Cell Disease and Acute Chest Syndrome: a Single-Center Experience.
    Hemoglobin. 2020;44:71-77.
    >> Share

  203. CHEN YJ, Li YQ, Liu Q, Tang LY, et al
    A Chinese Male with Normal Hematological Indices and High Hb A2 Levels in beta-Thalassemia Trait.
    Hemoglobin. 2020;44:131-133.
    >> Share

    January 2020
  204. SARIHI R, Amirizadeh N, Oodi A, Azarkeivan A, et al
    Distribution of Red Blood Cell Alloantibodies Among Transfusion-Dependent beta-Thalassemia Patients in Different Population of Iran: Effect of Ethnicity.
    Hemoglobin. 2020;44:31-36.
    >> Share

  205. BELISARIO AR, Carneiro-Proietti AB, Sabino EC, Araujo A, et al
    Hb S/beta-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.
    Hemoglobin. 2020;44:1-9.
    >> Share

  206. MASHON RS, Das R, Dhawan R, Kakkar N, et al
    Hb Rush (HBB: c.304G>C): A Rare Variant Hemoglobin Mimicking the Hb S (HBB: c.20A>T) Variant on High Performance Liquid Chromatography.
    Hemoglobin. 2020;44:64-66.
    >> Share

  207. MIR SA, Alshehri BM, Alaidarous M, Banawas SS, et al
    Prevalence of Hemoglobinopathies (beta-Thalassemia and Sickle Cell Trait) in the Adult Population of Al Majma'ah, Saudi Arabia.
    Hemoglobin. 2020;44:47-50.
    >> Share

  208. NAZ S, Rehman SU, Shakeel M, Rehman H, et al
    Molecular Heterogeneity of beta-Thalassemia in the Kohat Region, Khyber Pakhtunkhwa Province, Pakistan.
    Hemoglobin. 2020;44:37-41.
    >> Share

  209. AL-RIYAMI AZ, Daar S, Kindi SA, Madhani AA, et al
    alpha-Globin Genotypes Associated with Hb H Disease: A Report from Oman and a Review of the Literature from the Eastern Mediterranean Region.
    Hemoglobin. 2020;44:20-26.
    >> Share

  210. ROPERO P, Arbeteta J, Nieto JM, Gonzalez FA, et al
    Nondeletional alpha-Thalassemia: Two New Mutations on the alpha2 Gene.
    Hemoglobin. 2020;44:17-19.
    >> Share

  211. VAN GAMMEREN AJ, Pelkmans L, Endschot CCWV, Roelofsen-de Beer RJAC, et al
    An Unusual Compound Heterozygosity for Hb O-Arab (HBB: c.364G>A) and Hb D-Los Angeles (HBB: c.364G>C).
    Hemoglobin. 2020;44:61-63.
    >> Share

  212. LUO H, Zou Y, Liu Y
    A Novel beta-Thalassemia Mutation [IVS-I-6 (T>G), HBB: c.92+6T>G] in a Chinese Family.
    Hemoglobin. 2020;44:55-57.
    >> Share

  213. CHEN X, Luo S, Huang J, Yuan D, et al
    Diagnosis and Prenatal Diagnosis in a Chinese Family Carrying the Rare alpha-Thalassemia Gene HBA2: c.1A>G Mutation.
    Hemoglobin. 2020;44:51-54.
    >> Share

  214. SAKAMOTO A, Nakadate H, Tada K, Yamashiro Y, et al
    A Japanese Family with the Unstable Hb Sydney (HBB: c.203T>C) Variant and Persistent Low Hemoglobin Oxygen Saturation.
    Hemoglobin. 2020;44:58-60.
    >> Share

  215. SHOUJAA A, Moasses F, Mukhalalaty Y, Murad H, et al
    Genotype/Phenotype Correlation of beta-Thalassemia in Syrian Patients: A Cross-Sectional Study.
    Hemoglobin. 2020;44:42-46.
    >> Share

  216. SAJADPOUR Z, Amini-Farsani Z, Motovali-Bashi M, Yadollahi M, et al
    Association between Different Polymorphic Markers and beta-Thalassemia Intermedia in Central Iran.
    Hemoglobin. 2020;44:27-30.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016